Application Know How. Promptly after the Effective Date, SSI shall transfer to Evaxion all Application Know How. SSI shall confirm in writing to Evaxion that such transfer is complete after it has delivered to Evaxion all of such Application Know How. SSI shall reasonably assist Evaxion, at Evaxion’s request, in the use and understanding of the Application Know How and Licensed Adjuvant, including providing responses to follow-up or ad-hoc queries via email or telephone, provided, however, that Personnel designated by Evaxion to receive such advice must be fully trained and experienced in the formulation of adjuvants for vaccine use in humans.
Appears in 2 contracts
Sources: Supply, Patent, Know How & Trademark Licence Agreement (Evaxion Biotech a/S), Supply, Patent, Know How & Trademark Licence Agreement (Evaxion Biotech a/S)